Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

计划入组 260 人 · 首次发布于 2005 年 5 月 9 日

ATX-MS-1467 in Patients With Relapsing Forms of Multiple Sclerosis

计划入组 43 人 · 首次发布于 2010 年 4 月 2 日

Multiple Doses of Anti-NOGO A in Relapsing Forms of Multiple Sclerosis

计划入组 3 人 · 首次发布于 2011 年 9 月 19 日

Peginterferon beta-1a(Plegridy)

Diroximel fumarate(Vumerity)

C₁₁H₁₃NO₆ · Rx

Human interferon beta

MULTIPLE SCLEROSIS CENTER OF CALIFORNIA

United States

National Multiple Sclerosis Society

United States

MS CENTER OF GREATER WASHINGTON, P.C.

United States

Biogen Completes Phase 2 Trial of BIIB091 for Relapsing Multiple Sclerosis

Ocrevus Shows Long-Term Benefits as First-Line Treatment for Early Relapsing MS

Lupin Receives Tentative FDA Approval for Generic Siponimod Multiple Sclerosis Treatment